Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Changes of apoptosis in tumor tissues with time after irreversible electroporation.

Kim HB, Sung CK, Baik KY, Moon KW, Kim HS, Yi JH, Jung JH, Moon MH, Choi OK.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):651-6. doi: 10.1016/j.bbrc.2013.05.039. Epub 2013 May 17.

PMID:
23688425
2.

Irreversible electroporation for the ablation of liver tumors: are we there yet?

Charpentier KP.

Arch Surg. 2012 Nov;147(11):1053-61. doi: 10.1001/2013.jamasurg.100. Review.

PMID:
23165618
3.

Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.

Guo Y, Zhang Y, Nijm GM, Sahakian AV, Yang GY, Omary RA, Larson AC.

Radiology. 2011 Feb;258(2):461-8. doi: 10.1148/radiol.10100645. Epub 2010 Dec 3.

4.

Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Zhang Y, White SB, Nicolai JR, Zhang Z, West DL, Kim DH, Goodwin AL, Miller FH, Omary RA, Larson AC.

Radiology. 2014 Jun;271(3):721-9. doi: 10.1148/radiol.14130989. Epub 2014 Feb 18.

5.

Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.

Davalos RV, Bhonsle S, Neal RE 2nd.

Prostate. 2015 Jul 1;75(10):1114-8. doi: 10.1002/pros.22986. Epub 2015 Mar 23.

PMID:
25809014
6.

Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model.

Wendler JJ, Porsch M, Hühne S, Baumunk D, Buhtz P, Fischbach F, Pech M, Mahnkopf D, Kropf S, Roessner A, Ricke J, Schostak M, Liehr UB.

Cardiovasc Intervent Radiol. 2013 Apr;36(2):512-20. doi: 10.1007/s00270-012-0452-7. Epub 2012 Aug 15.

PMID:
22893419
7.

A statistical model for multidimensional irreversible electroporation cell death in tissue.

Golberg A, Rubinsky B.

Biomed Eng Online. 2010 Feb 26;9:13. doi: 10.1186/1475-925X-9-13.

8.

In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.

Neal RE 2nd, Millar JL, Kavnoudias H, Royce P, Rosenfeldt F, Pham A, Smith R, Davalos RV, Thomson KR.

Prostate. 2014 May;74(5):458-68. doi: 10.1002/pros.22760. Epub 2014 Jan 17.

PMID:
24442790
9.

Irreversible electroporation: an in vivo study with dorsal skin fold chamber.

Qin Z, Jiang J, Long G, Lindgren B, Bischof JC.

Ann Biomed Eng. 2013 Mar;41(3):619-29. doi: 10.1007/s10439-012-0686-1. Epub 2012 Nov 22.

PMID:
23180025
10.

MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.

Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, Nijm GM, Sahakian AV, Omary RA, Larson AC.

Radiology. 2010 Aug;256(2):424-32. doi: 10.1148/radiol.10091955.

11.

Irreversible electroporation ablation: is all the damage nonthermal?

Faroja M, Ahmed M, Appelbaum L, Ben-David E, Moussa M, Sosna J, Nissenbaum I, Goldberg SN.

Radiology. 2013 Feb;266(2):462-70. doi: 10.1148/radiol.12120609. Epub 2012 Nov 20.

PMID:
23169795
12.

Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Zhang Z, Li W, Procissi D, Tyler P, Omary RA, Larson AC.

Nanomedicine (Lond). 2014;9(8):1181-92. doi: 10.2217/nnm.13.72. Epub 2013 Sep 11.

13.

Irreversible electroporation: a new ablation modality--clinical implications.

Rubinsky B, Onik G, Mikus P.

Technol Cancer Res Treat. 2007 Feb;6(1):37-48.

PMID:
17241099
14.

Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.

Bulvik BE, Rozenblum N, Gourevich S, Ahmed M, Andriyanov AV, Galun E, Goldberg SN.

Radiology. 2016 Aug;280(2):413-24. doi: 10.1148/radiol.2015151166. Epub 2016 Jan 27.

PMID:
27429143
15.

Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.

Beyer LP, Pregler B, Nießen C, Michalik K, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P.

Clin Hemorheol Microcirc. 2016;64(3):501-506. doi: 10.3233/CH-168125.

PMID:
27935553
16.

[Irreversible electroporation: local, non-thermal, ablation therapy of malignant tumours].

Janík V, Skrabalová D, Gürlich R, Málek J.

Cas Lek Cesk. 2013;152(2):67-75. Czech.

PMID:
23641678
17.

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.

van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, Laguna Pes MP, Veelo DP, Savci Heijink CD, Engelbrecht MR, Wijkstra H, de Reijke TM, de la Rosette JJ.

BMJ Open. 2014 Oct 29;4(10):e006382. doi: 10.1136/bmjopen-2014-006382.

18.
19.

Introduction to Irreversible Electroporation--Principles and Techniques.

Thomson KR, Kavnoudias H, Neal RE 2nd.

Tech Vasc Interv Radiol. 2015 Sep;18(3):128-34. doi: 10.1053/j.tvir.2015.06.002. Epub 2015 Jun 18. Review.

PMID:
26365541
20.

Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.

Dunki-Jacobs EM, Philips P, Martin RC 2nd.

Br J Surg. 2014 Aug;101(9):1113-21. doi: 10.1002/bjs.9536. Epub 2014 Jun 24.

PMID:
24961953

Supplemental Content

Support Center